HomeCompareRTMVF vs MRK

RTMVF vs MRK: Dividend Comparison 2026

RTMVF yields 2.22% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $7.8K in total portfolio value
10 years
RTMVF
RTMVF
● Live price
2.22%
Share price
$6.09
Annual div
$0.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.0K
Annual income
$256.55
Full RTMVF calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — RTMVF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRTMVFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RTMVF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RTMVF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RTMVF
Annual income on $10K today (after 15% tax)
$188.90/yr
After 10yr DRIP, annual income (after tax)
$218.07/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MRK beats the other by $589.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RTMVF + MRK for your $10,000?

RTMVF: 50%MRK: 50%
100% MRK50/50100% RTMVF
Portfolio after 10yr
$26.9K
Annual income
$603.43/yr
Blended yield
2.25%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RTMVF
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
67.5
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RTMVF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRTMVFMRK
Forward yield2.22%3.25%
Annual dividend / share$0.14$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR0%8.2%
Portfolio after 10y$23.0K$30.7K
Annual income after 10y$256.55$950.29
Total dividends collected$2.4K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: RTMVF vs MRK ($10,000, DRIP)

YearRTMVF PortfolioRTMVF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,922$222.23$11,192$351.54$270.00MRK
2$11,914$226.85$12,524$392.70$610.00MRK
3$12,979$231.25$14,015$438.65$1.0KMRK
4$14,123$235.45$15,682$489.96$1.6KMRK
5$15,351$239.44$17,547$547.23$2.2KMRK
6$16,669$243.23$19,632$611.16$3.0KMRK
7$18,082$246.83$21,963$682.53$3.9KMRK
8$19,598$250.25$24,571$762.18$5.0KMRK
9$21,224$253.49$27,486$851.08$6.3KMRK
10$22,966$256.55$30,745$950.29$7.8KMRK

RTMVF vs MRK: Complete Analysis 2026

RTMVFStock

Rightmove plc, together with its subsidiaries, operates property portals in the United Kingdom and internationally. It operates through Agency, New Homes, and Other segments. The Agency segment provides property resale and letting advertising services on its platforms. It also offers tenant references and rent guarantee insurance services to landlords. The New Homes segment provides property advertising services to new home developers and housing associations on its platforms. The Other segment offers overseas and commercial property advertising services; and non-property advertising services that include third party advertising and data services. It serves estate agents, lettings agents, and new homes developers. Rightmove plc was founded in 2000 and is based in Milton Keynes, the United Kingdom.

Full RTMVF Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this RTMVF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RTMVF vs SCHDRTMVF vs JEPIRTMVF vs ORTMVF vs KORTMVF vs MAINRTMVF vs JNJRTMVF vs ABBVRTMVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.